I am a
Home I AM A Search Login

Papers of the Week


Papers: 12 Mar 2022 - 18 Mar 2022


Pharmacology/Drug Development


2022 Mar 14


Biomed Pharmacother


149

The comparison of dexketoprofen and other painkilling medications (review from 2018 to 2021).

Authors

Kuczyńska J, Pawlak A, Nieradko-Iwanicka B
Biomed Pharmacother. 2022 Mar 14; 149:112819.
PMID: 35299123.

Abstract

Dexketoprofen is an enantiomer of ketoprofen (S+) that belongs to nonsteroidal anti-inflammatory drugs and has analgesic, anti-inflammatory, and antipyretic properties. Dexketoprofen has a stronger effect than ketoprofen, which makes it a readily used preparation. The review aims to find in recent original publications data about dexketoprofen and its comparison with other painkilling medications. The systematic literature review was conducted in November 2021 (2018 onwards). We selected 12 articles from PubMed, Google Scholar, Medline Complete databases. In the last 4 years, there have been many publications that shed a new light on dexketoprofen. The article is a comparative analysis of dexketoprofen's action vs other nonsteroidal anti-inflammatory drugs and the combination of dexketoprofen with tramadol vs paracetamol with tramadol. The findings of the review confirm that dexketoprofen is a very good pain reliever more potent than paracetamol. Dexketoprofen produces similar effects to lidocaine and dexmedetomidine. Complex preparations containing dexketoprofen and tramadol are very effective painkilling tandem and are more effective than tramadol and paracetamol therapy in the treatment of acute pain.